Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Editas Medicine, Inc. EDIT

Set alert

Price alert · EDIT

All alert types
2.67 USD -0.26 -8.87%

At close · Oct 30

2.70 +0.03 +1.12%

After hours · Oct 30, 5:35 PM ET

Bid
2.66 × 2
Ask
2.67 × 2
2.60 Day range 2.92
1.66 52-week range 3.75
YTD
+30.24%
1 year
-11.30%
Open
2.89
Prev close
2.93
Mkt cap
410.06M
Vol
2.91M
Avg vol
2.66M
EPS
-0.68
P/E
0.00
Div yield
0.00%
More statistics
Low
2.60
High
2.92
Forward P/E
-0.53
Beta
2.01
Short ratio
6.70
Inst. own
70.94%
Dividend
0.00
Ex-div date
50-d avg
2.60
200-d avg
4.55
1y target
3.67

1D chart

Chart tools
Interval
1m5m15m30m

Signals (45)
NameTimeAgo
RSI: Overbought3:59 PM2 days ago
SMA: Bullish3:55 PM2 days ago
MACD: Buy Signal3:55 PM2 days ago
MACD: Sell Signal3:35 PM2 days ago
RSI: Overbought3:24 PM2 days ago
MACD: Buy Signal3:21 PM2 days ago
MACD: Sell Signal3:20 PM2 days ago
SMA: Bullish3:10 PM2 days ago
SMA: Bullish3:10 PM2 days ago
MACD: Buy Signal3:10 PM2 days ago
MACD: Sell Signal3:01 PM2 days ago
MACD: Buy Signal2:56 PM2 days ago
MACD: Sell Signal2:55 PM2 days ago
MACD: Buy Signal2:41 PM2 days ago
MACD: Sell Signal2:35 PM2 days ago
MACD: Buy Signal2:33 PM2 days ago
MACD: Sell Signal2:30 PM2 days ago
MACD: Buy Signal2:29 PM2 days ago
MACD: Sell Signal2:25 PM2 days ago
MACD: Buy Signal2:04 PM2 days ago
MACD: Sell Signal2:03 PM2 days ago
MACD: Buy Signal2:01 PM2 days ago
MACD: Sell Signal2:00 PM2 days ago
RSI: Oversold1:28 PM2 days ago
RSI: Oversold1:24 PM2 days ago
MACD: Buy Signal1:15 PM2 days ago
RSI: Oversold1:00 PM2 days ago
MACD: Sell Signal12:50 PM2 days ago
MACD: Buy Signal12:40 PM2 days ago
MACD: Sell Signal12:39 PM2 days ago
MACD: Buy Signal12:38 PM2 days ago
MACD: Sell Signal12:31 PM2 days ago
MACD: Buy Signal12:29 PM2 days ago
MACD: Sell Signal12:27 PM2 days ago
SMA: Bearish12:00 PM2 days ago
SMA: Bullish11:59 AM2 days ago
MACD: Buy Signal11:49 AM2 days ago
RSI: Oversold11:40 AM2 days ago
RSI: Oversold11:31 AM2 days ago
SMA: Bearish11:27 AM2 days ago
MACD: Sell Signal11:09 AM2 days ago
RSI: Overbought11:05 AM2 days ago
RSI: Overbought11:00 AM2 days ago
RSI: Overbought10:51 AM2 days ago
RSI: Oversold10:10 AM2 days ago

Financial health

Altman Z-Score

-8.05 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 3
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 3
  • P/E 1
  • P/B 2

Valuation

P/E -1.1×
FY 2016: -5.4×FY 2017: -10.3×FY 2018: -9.8×FY 2019: -12.0×FY 2020: -35.4×FY 2021: -9.3×FY 2022: -2.8×FY 2023: -5.0×FY 2024: -0.4×FY 2025: -1.1×
FY 2016 5y median -2.8× FY 2025
P/S 4.5×
FY 2016: 86.4×FY 2017: 90.3×FY 2018: 33.5×FY 2019: 72.1×FY 2020: 45.3×FY 2021: 70.3×FY 2022: 30.9×FY 2023: 9.9×FY 2024: 3.2×FY 2025: 4.5×
FY 2016 5y median 9.9× FY 2025
P/B 6.7×
FY 2016: 3.9×FY 2017: 6.0×FY 2018: 4.5×FY 2019: 5.6×FY 2020: 10.4×FY 2021: 3.2×FY 2022: 1.7×FY 2023: 2.2×FY 2024: 0.8×FY 2025: 6.7×
FY 2016 5y median 2.2× FY 2025
P/FCF -1.1×
FY 2016: -9.8×FY 2017: -108×FY 2018: -21.2×FY 2019: -31.6×FY 2020: -22.0×FY 2021: -10.5×FY 2022: -3.4×FY 2023: -5.6×FY 2024: -0.5×FY 2025: -1.1×
FY 2016 5y median -3.4× FY 2025
EV/EBITDA -0.8×
FY 2016: -3.9×FY 2017: -9.7×FY 2018: -8.8×FY 2019: -9.2×FY 2020: -30.5×FY 2021: -8.6×FY 2022: -2.4×FY 2023: -4.7×FY 2024: -0.0×FY 2025: -0.8×
FY 2016 5y median -2.4× FY 2025
EV/Sales 2.8×
FY 2016: 61.6×FY 2017: 82.0×FY 2018: 30.3×FY 2019: 61.9×FY 2020: 44.0×FY 2021: 63.3×FY 2022: 25.9×FY 2023: 8.9×FY 2024: 0.2×FY 2025: 2.8×
FY 2016 5y median 8.9× FY 2025
FCF Yield -91.2%
FY 2016: -10.2%FY 2017: -0.9%FY 2018: -4.7%FY 2019: -3.2%FY 2020: -4.6%FY 2021: -9.6%FY 2022: -29.8%FY 2023: -17.8%FY 2024: -209.5%FY 2025: -91.2%
FY 2016 5y median -29.8% FY 2025

Profitability

Gross Margin 100.0%
FY 2016: -841.3%FY 2017: -505.8%FY 2018: -183.9%FY 2019: -372.0%FY 2020: -74.1%FY 2021: 80.2%FY 2022: 67.9%FY 2023: 92.2%FY 2024: -516.6%FY 2025: 100.0%
FY 2016 5y median 80.2% FY 2025
Operating Margin -245.2%
FY 2016: -1605.6%FY 2017: -873.6%FY 2018: -356.1%FY 2019: -686.4%FY 2020: -148.6%FY 2021: -756.1%FY 2022: -1146.3%FY 2023: -216.6%FY 2024: -777.2%FY 2025: -245.2%
FY 2016 5y median -756.1% FY 2025
Net Margin -395.0%
FY 2016: -1605.5%FY 2017: -876.5%FY 2018: -344.3%FY 2019: -651.4%FY 2020: -127.8%FY 2021: -753.6%FY 2022: -1118.3%FY 2023: -196.1%FY 2024: -733.7%FY 2025: -395.0%
FY 2016 5y median -733.7% FY 2025
ROE -586.6%
FY 2016: -72.2%FY 2017: -57.8%FY 2018: -46.6%FY 2019: -51.0%FY 2020: -29.5%FY 2021: -34.8%FY 2022: -61.1%FY 2023: -43.9%FY 2024: -176.6%FY 2025: -586.6%
FY 2016 5y median -61.1% FY 2025
ROIC -65.6%
FY 2016: -47.2%FY 2017: -34.5%FY 2018: -29.6%FY 2019: -31.0%FY 2020: -25.9%FY 2021: -30.1%FY 2022: -48.6%FY 2023: -36.8%FY 2024: -90.0%FY 2025: -65.6%
FY 2016 5y median -48.6% FY 2025
ROA -85.8%
FY 2016: -42.4%FY 2017: -32.2%FY 2018: -26.2%FY 2019: -26.3%FY 2020: -20.3%FY 2021: -28.4%FY 2022: -42.9%FY 2023: -30.7%FY 2024: -69.4%FY 2025: -85.8%
FY 2016 5y median -42.9% FY 2025

Growth (YoY)

Revenue 25.4%
FY 2016: 271.6%FY 2017: 126.8%FY 2018: 132.6%FY 2019: -35.7%FY 2020: 341.9%FY 2021: -71.8%FY 2022: -22.8%FY 2023: 296.3%FY 2024: -58.6%FY 2025: 25.4%
FY 2016 FY 2025
Operating Income 60.4%
FY 2016: -175.2%FY 2017: -23.4%FY 2018: 5.2%FY 2019: -23.9%FY 2020: 4.3%FY 2021: -43.2%FY 2022: -17.0%FY 2023: 25.1%FY 2024: -48.5%FY 2025: 60.4%
FY 2016 FY 2025
EPS (diluted) 37.5%
FY 2016: -48.0%FY 2017: 1.3%FY 2018: 21.8%FY 2019: -6.0%FY 2020: 19.8%FY 2021: -43.9%FY 2022: -12.6%FY 2023: 37.1%FY 2024: -42.6%FY 2025: 37.5%
FY 2016 FY 2025
Free Cash Flow 24.3%
FY 2016: -681.7%FY 2017: 78.5%FY 2018: -339.7%FY 2019: 7.2%FY 2020: -299.3%FY 2021: 8.1%FY 2022: -5.6%FY 2023: 24.6%FY 2024: -60.1%FY 2025: 24.3%
FY 2016 FY 2025

Financial Health

Current Ratio 3.5×
FY 2016: 5.7×FY 2017: 9.1×FY 2018: 10.4×FY 2019: 7.7×FY 2020: 7.2×FY 2021: 10.8×FY 2022: 5.9×FY 2023: 5.4×FY 2024: 3.7×FY 2025: 3.5×
FY 2016 5y median 5.4× FY 2025
Quick Ratio 3.5×
FY 2016: 5.6×FY 2017: 9.0×FY 2018: 10.4×FY 2019: 7.7×FY 2020: 7.2×FY 2021: 10.8×FY 2022: 5.9×FY 2023: 5.4×FY 2024: 3.7×FY 2025: 3.5×
FY 2016 5y median 5.4× FY 2025
Debt / Equity 2.8×
FY 2016: 0.3×FY 2017: 0.2×FY 2018: 0.1×FY 2019: 0.1×FY 2020: 0.1×FY 2021: 0.0×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.3×FY 2025: 2.8×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA 0.5×
FY 2016: 1.6×FY 2017: 1.0×FY 2018: 0.9×FY 2019: 1.5×FY 2020: 0.9×FY 2021: 0.9×FY 2022: 0.5×FY 2023: 0.5×FY 2024: 0.4×FY 2025: 0.5×
FY 2016 5y median 0.5× FY 2025
Interest Coverage -16.1×
FY 2016: 0.0×FY 2017: -123×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: -16.1×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31